Dan Victor

The ETF is worth owning for exposure to the entire solar value chain.

Brink’s is growing market share at multiple points of the cash economy.

The company has benefited from consumer conditions. Its expansion plans are on pace.

The company is expanding into higher margin and faster growth offerings.

The stock is still worth buying at around 10 times earnings.

The stock plunged after a disappointing revision lower to the company’s full-year growth target. 

Belden has transformed itself to profit from the AI data-center trend but still trades for value.

The selloff is a buying opportunity for the former Barron’s stock pick.

International expansion and surging profitability help make Remitly Global stock a buy.

John Wiley & Sons licenses its content to AI applications, transforming its revenue base.

The stock is down since Barron’s picked it, but there are reasons to expect better days ahead.

Logitech is reimagining its entire lineup of workplace and gaming devices. Its stock can rally 40%.

Cellebrite’s growth outlook and accelerating profitability make for a compelling opportunity.

The Global X Defense Tech ETF allows investors to profit from the future of warfare.

Medtronic offers high growth potential in addition to discounted valuation.

A challenging construction environment, and AI disruption have weighed on the stock.

Cinemark has gained market share and stands out with quality fundamentals.

The stock may ultimately benefit from AI, but displacement threats are real as well.

Shares have underperformed amid uncertainty surrounding the company’s prospects.

The company is leveraging AI as a growth driver. Its stock should continue to rally.